Edwards Lifesciences Corp at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 10, 2022 / 04:15PM GMT
Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst

Welcome back, everyone. I'm Robbie Marcus, the medtech analyst at JPMorgan. Very happy to introduce our next company, Edwards Lifesciences. We're going to have CEO, Mike Mussallem, do the presentation and joining us for Q&A afterwards is CFO, Scott Ullem. Just a little housekeeping, feel free to e-mail me any questions or submit through the conference website, and I'll do my best to ask them.

With that, Mike, I'll turn it over to you and join you in a little bit.

Michael A. Mussallem - Edwards Lifesciences Corporation - Chairman & CEO

All right. Well, thanks a lot, Robbie, and hello, everybody. I can't believe this is the 40th Annual JPMorgan Healthcare Conference. I think I've been at a great number of these.

So today, we'll be making some forward-looking statements that involves risks. You can find a list of those on our website and on file with the SEC. And we'll also be using some non-GAAP financial measures, which are helpful, and we have reconciliations

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot